Aptose Biosciences Stock News

The trading price of Aptose Biosciences Inc. (NASDAQ:APTO) closed lower on Tuesday, December 14, closing at $1.11, -43.08% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

Aptose Biosciences (TSX:APT)(NASDAQ:APTO) results for its leukemia drug were met with a poor reaction, sending shares down 45%. The post Why Aptose Biosciences Plunged 45% Yesterday appeared first on The Motley Fool Canada .

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Vaccitech To Buy Avidea For $40M Vaccitech plc (NASDAQ: VACC) announced that it has acquired U.S.-base

Aptose Biosciences Inc (NASDAQ: APTO) presented data from the ongoing Phase 1/2 study of HM43239 in patients relapsed or refractory acute myeloid leukemia (AML) who had received at least one prior

HM43239 Data Featured in Oral Presentation at the American Society of Hematology Annual Meeting

Community Health Systems' (CYH) cost-control initiatives are likely to lower costs to a great extent and boost the bottom line.

An FDA advisory committee believes Reata's (RETA) bardoxolone study data does not support the effectiveness of the candidate in slowing the progression of CKD in patients with Alport syndrome.

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) shares reached a new 52-week low during trading on Monday . The stock traded as low as C$2.51 and last traded at C$2.58, with a volume of 13806 shares traded. The stock had previously closed at C$2.56. Several research analysts recently issued reports on APS shares. Cantor Fitzgerald reaffirmed an […]

Aptose Biosciences Inc. (NASDAQ:APTO) concluded the trading at $2.09 on Thursday, December 02 with a rise of 0.97% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.07 and 5Y monthly beta was reading 1.31 with its price kept floating in the … Aptose Biosciences Inc. (APTO) Could Be Possessing A Gold Mine Read More »

Aptose Biosciences Inc. (NASDAQ:APTO) has a beta value of 1.66 and has seen 1.52 million shares traded in the last trading session. The company, currently valued at $195.54M, closed the last trade at $2.20 per share which meant it gained $0.02 on the day or 0.92% during that session. The APTO stock price is -230.45% Why Acquire Shares Of Aptose Biosciences Inc. (APTO)? Read More »

Aptose Biosciences Inc. (NASDAQ:APTO) (TSE:APS) saw unusually large options trading on Monday. Traders purchased 9,856 call options on the stock. This represents an increase of 2,557% compared to the average volume of 371 call options. In other Aptose Biosciences news, VP Rafael Bejar acquired 10,000 shares of the companys stock in a transaction on Friday, []

HM43239 clinical update in AML after oral presentation at 2021 ASH Annual MeetingLuxeptinib clinical update in AML and B-cell cancers

Investors need to pay close attention to Aptose Biosciences (APTO) stock based on the movements in the options market lately.

Investors need to pay close attention to Aptose Biosciences (APTO) stock based on the movements in the options market lately.

Wall Street brokerages expect Aptose Biosciences Inc. (NASDAQ:APTO) (TSE:APS) to report earnings of ($0.18) per share for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Aptose Biosciences earnings. The highest EPS estimate is ($0.16) and the lowest is ($0.20). Aptose Biosciences reported earnings of ($0.17) per share in the same []